1. Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study. (3rd October 2022) Authors: Alonso, R; Arroyo-Olivares, R; Muniz-Grijalvo, O; Diaz-Diaz, J L; Sanchez Munoz-Torrero, J; Zambon, D; Fuentes-Jimenez, F; Romero, M J; Aguado, R; Alvarez-Banos, P; Manas, M D; Arrieta, F; Gonzalez-Bustos, P; Argueso, R; Mata, P Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗